Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FB301 With or Without Pre-treatment in Bacterial Vaginosis
NCT07481955Phase 2Recruiting
- Sponsor
- Freya Biosciences
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of FB301 in bacterial vaginosis (BV), sponsored by Freya Biosciences. Started Mar 2026; status: recruiting.
02
Drugs
FB301
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07481955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07481955.